Cargando…

Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center

PURPOSE: Infections remain a major challenge in the treatment of acute myeloid leukemia (AML). Induction-related mortality reported in the literature is approximately < 5% in clinical trials. However, the real-world scenario is different, especially in developing countries, given the high inciden...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Hasmukh, Rengaraj, Karthik, Sharma, Vibhor, Bonda, Avinash, Chanana, Raajit, Thorat, Jayashree, Ronghe, Ashwini, Biswas, Sanjay, Nayak, Lingaraj, Tembhare, Prashant, Subramnian, Papagudi, Shetty, Dhanalaxmi, Patkar, Nikhil, Bagal, Bhausaheb, Sengar, Manju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713585/
https://www.ncbi.nlm.nih.gov/pubmed/33156719
http://dx.doi.org/10.1200/GO.20.00240
_version_ 1783618590276059136
author Jain, Hasmukh
Rengaraj, Karthik
Sharma, Vibhor
Bonda, Avinash
Chanana, Raajit
Thorat, Jayashree
Ronghe, Ashwini
Biswas, Sanjay
Nayak, Lingaraj
Tembhare, Prashant
Subramnian, Papagudi
Shetty, Dhanalaxmi
Patkar, Nikhil
Bagal, Bhausaheb
Sengar, Manju
author_facet Jain, Hasmukh
Rengaraj, Karthik
Sharma, Vibhor
Bonda, Avinash
Chanana, Raajit
Thorat, Jayashree
Ronghe, Ashwini
Biswas, Sanjay
Nayak, Lingaraj
Tembhare, Prashant
Subramnian, Papagudi
Shetty, Dhanalaxmi
Patkar, Nikhil
Bagal, Bhausaheb
Sengar, Manju
author_sort Jain, Hasmukh
collection PubMed
description PURPOSE: Infections remain a major challenge in the treatment of acute myeloid leukemia (AML). Induction-related mortality reported in the literature is approximately < 5% in clinical trials. However, the real-world scenario is different, especially in developing countries, given the high incidence of multidrug-resistant (MDR) organisms, high incidence of fungal pneumonia at baseline, and significant delay before initiation of chemotherapy. We aimed to look at contemporary infections and infection-related mortality and analyze the patterns of infections. MATERIALS AND METHODS: This retrospective study was conducted at a large tertiary care oncology center in India. Patients with newly diagnosed AML who were older than age 15 years, considered fit for intensive therapy, and treated in the general wards of the adult hematolymphoid unit from March 1, 2014, until December 31, 2015, were included. RESULTS: One hundred twenty-one patients were treated during the study period. The most common presenting complaint was fever (85%). The focus of infection at presentation was found in 63% of patients, with respiratory infection being the most common (47%). MDR organisms were isolated in 55% of patients during induction from various foci. Klebsiella pneumoniae was the most common blood culture isolate (42.9%). Fungal pneumonia was diagnosed in 55% of patients during induction despite antifungal prophylaxis. Treatment-related mortality was 10.7% in all phases, with an induction mortality rate of 7.4%. Complete remission was attained in 69% of patients. Of all patients who received induction chemotherapy, 74% completed all three consolidation cycles. The 121 patients were followed up for a median period of 53 months. Four-year event-free survival was 35.8%, and 4-year overall survival was 41.5%. CONCLUSION: Infections and infection-related mortality are major challenges during AML induction. Gram-negative MDR and fungal infections are particularly common in our region.
format Online
Article
Text
id pubmed-7713585
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-77135852020-12-04 Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center Jain, Hasmukh Rengaraj, Karthik Sharma, Vibhor Bonda, Avinash Chanana, Raajit Thorat, Jayashree Ronghe, Ashwini Biswas, Sanjay Nayak, Lingaraj Tembhare, Prashant Subramnian, Papagudi Shetty, Dhanalaxmi Patkar, Nikhil Bagal, Bhausaheb Sengar, Manju JCO Glob Oncol ORIGINAL REPORTS PURPOSE: Infections remain a major challenge in the treatment of acute myeloid leukemia (AML). Induction-related mortality reported in the literature is approximately < 5% in clinical trials. However, the real-world scenario is different, especially in developing countries, given the high incidence of multidrug-resistant (MDR) organisms, high incidence of fungal pneumonia at baseline, and significant delay before initiation of chemotherapy. We aimed to look at contemporary infections and infection-related mortality and analyze the patterns of infections. MATERIALS AND METHODS: This retrospective study was conducted at a large tertiary care oncology center in India. Patients with newly diagnosed AML who were older than age 15 years, considered fit for intensive therapy, and treated in the general wards of the adult hematolymphoid unit from March 1, 2014, until December 31, 2015, were included. RESULTS: One hundred twenty-one patients were treated during the study period. The most common presenting complaint was fever (85%). The focus of infection at presentation was found in 63% of patients, with respiratory infection being the most common (47%). MDR organisms were isolated in 55% of patients during induction from various foci. Klebsiella pneumoniae was the most common blood culture isolate (42.9%). Fungal pneumonia was diagnosed in 55% of patients during induction despite antifungal prophylaxis. Treatment-related mortality was 10.7% in all phases, with an induction mortality rate of 7.4%. Complete remission was attained in 69% of patients. Of all patients who received induction chemotherapy, 74% completed all three consolidation cycles. The 121 patients were followed up for a median period of 53 months. Four-year event-free survival was 35.8%, and 4-year overall survival was 41.5%. CONCLUSION: Infections and infection-related mortality are major challenges during AML induction. Gram-negative MDR and fungal infections are particularly common in our region. American Society of Clinical Oncology 2020-11-06 /pmc/articles/PMC7713585/ /pubmed/33156719 http://dx.doi.org/10.1200/GO.20.00240 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle ORIGINAL REPORTS
Jain, Hasmukh
Rengaraj, Karthik
Sharma, Vibhor
Bonda, Avinash
Chanana, Raajit
Thorat, Jayashree
Ronghe, Ashwini
Biswas, Sanjay
Nayak, Lingaraj
Tembhare, Prashant
Subramnian, Papagudi
Shetty, Dhanalaxmi
Patkar, Nikhil
Bagal, Bhausaheb
Sengar, Manju
Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center
title Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center
title_full Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center
title_fullStr Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center
title_full_unstemmed Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center
title_short Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center
title_sort infection prevalence in adolescents and adults with acute myeloid leukemia treated in an indian tertiary care center
topic ORIGINAL REPORTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713585/
https://www.ncbi.nlm.nih.gov/pubmed/33156719
http://dx.doi.org/10.1200/GO.20.00240
work_keys_str_mv AT jainhasmukh infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT rengarajkarthik infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT sharmavibhor infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT bondaavinash infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT chananaraajit infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT thoratjayashree infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT rongheashwini infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT biswassanjay infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT nayaklingaraj infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT tembhareprashant infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT subramnianpapagudi infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT shettydhanalaxmi infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT patkarnikhil infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT bagalbhausaheb infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter
AT sengarmanju infectionprevalenceinadolescentsandadultswithacutemyeloidleukemiatreatedinanindiantertiarycarecenter